Injective news today centers on the Canary Staked INJ ETF, which began trading on Nasdaq on November 5, 2026. INJ was trading at $8.36, up 4.63% over 24 hours. The vehicle's debut makes it the first U.S. fund focused on staking the token, according to the uptick coinciding with the launch of the first U.S. fund dedicated to staking the token. Canary's fund is structured to put at least nine-tenths of its assets into staking, and Nasdaq approves listing of Canary Staked Injective ETF under ticker INJC. The listing took effect on November 5, following a trader alert issued the day before.